Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 13 studies | 24% ± 5% | |
| myofibroblast cell | 5 studies | 27% ± 13% | |
| oligodendrocyte precursor cell | 5 studies | 28% ± 8% | |
| adipocyte | 3 studies | 24% ± 11% |
Insufficient scRNA-seq data for expression of ANGPTL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 11059.56 | 459 / 459 | 95% | 72.32 | 1058 / 1118 |
| lung | 97% | 3568.17 | 561 / 578 | 90% | 57.40 | 1040 / 1155 |
| prostate | 97% | 3878.52 | 237 / 245 | 80% | 33.70 | 403 / 502 |
| intestine | 94% | 7666.89 | 904 / 966 | 80% | 47.58 | 422 / 527 |
| bladder | 100% | 9243.48 | 21 / 21 | 72% | 40.77 | 364 / 504 |
| esophagus | 87% | 3936.82 | 1257 / 1445 | 84% | 48.38 | 154 / 183 |
| uterus | 99% | 8667.71 | 169 / 170 | 65% | 40.74 | 298 / 459 |
| ovary | 100% | 6725.07 | 180 / 180 | 64% | 23.92 | 274 / 430 |
| skin | 88% | 3484.41 | 1584 / 1809 | 72% | 54.94 | 339 / 472 |
| thymus | 92% | 2564.69 | 601 / 653 | 64% | 18.73 | 390 / 605 |
| stomach | 56% | 3646.31 | 202 / 359 | 86% | 65.57 | 245 / 286 |
| brain | 42% | 1002.04 | 1100 / 2642 | 99% | 199.85 | 697 / 705 |
| adrenal gland | 50% | 907.44 | 128 / 258 | 86% | 63.54 | 197 / 230 |
| kidney | 34% | 847.81 | 30 / 89 | 72% | 63.00 | 648 / 901 |
| adipose | 100% | 16371.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5665.17 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 52.87 | 1 / 1 |
| blood vessel | 98% | 4239.25 | 1303 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 4887.70 | 837 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 5138.75 | 773 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 27.74 | 5 / 328 | 92% | 68.32 | 163 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 36.25 | 34 / 45 |
| eye | 0% | 0 | 0 / 0 | 50% | 10.39 | 40 / 80 |
| liver | 16% | 267.14 | 37 / 226 | 33% | 11.02 | 134 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 16.10 | 12 / 29 |
| peripheral blood | 0% | 4.15 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ANGPTL2 |
| Protein name | Angiopoietin-related protein 2 (Angiopoietin-like protein 2) |
| Synonyms | UNQ170/PRO196 ARP2 |
| Description | FUNCTION: Induces sprouting in endothelial cells through an autocrine and paracrine action. |
| Accessions | ENST00000373417.1 [Q9UKU9-2] Q9UKU9 ENST00000373425.8 [Q9UKU9-1] |